Reducing Fortescue's FVE by 3% on Cost and Capital Expenditure Headwinds
It built much of its capacity around the China boom peak and baked in a higher capital base than peers. This means returns are likely to lag the industry leaders who benefited from building ...
Anglo American targets $1.8B cost savings and copper growth to 1M tons by 2027
Discover key insights from Anglo American's Q4 2024 earnings call, including $1B cost savings, strategic portfolio moves, and future copper-focused growth.
Novel tool slashes opioid crisis costs by 30%, could save lives
A study published in the journal Decision Analysis unveils a powerful new tool to tackle the opioid crisis, offering a ...
CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles
CVRx , Inc. (NASDAQ:CVRX), a medical device company with a market capitalization of $382 million specializing in the development and commercialization of the Barostim therapy for heart failure and ...